By means of the spore fluorescent antibody technique, 31 strains of Clostridium botulinum types A (18 strains), B (10 strains) and F (3 strains) were found to belong to the same homogeneous group irrespective of their toxigenic types. Some strains of this species also cross-reacted with certain strains of Clostridium sporogenes types I, II and III and Clostridium histolyticum type II. By spore antigenic analysis it was found that Clostridium parabotulinum contained two components designated L and M, the former describing species specificity; the latter was the cross-reacting component shared by some strains of Clostridium sporogenes and Clostridium histolyticum. Following this, a scheme showing the distribution of spore antigenic components among various species of Clostridium was given.
INTRODUCTION
Strains of Clostridium botulinum are divided into six types (A-F) according to the antigenic specificity of the toxins they produce, whereas their biochemical activity separates them into proteolytic and non-proteolytic groups. Thus, proteolytic types A, B and F and non-proteolytic types B, C, D, E and F of Cl. botulinum exist. Sharing of somatic antigens among strains of proteolytic types A, B and F has been reported by Walker & Batty (1964) , Solomon, Lynt, Kautter & Lilly (1971) and . Partial crossagglutination of Cl. sporogenes with the somatic antisera of the proteolytic group of Cl. botulinum has also been observed by Mandia (1955) , Solomon et al. (1971) , and Lynt et al. (1972) . Except by means of the toxigenicity test it is impossible to distinguish Cl. botulinum from Cl. sporogenes on the basis of physiological or biochemical characteristics (Lynt et al. 1972) . Princewill (1979a) divided Cl. sporogenes into types by means of the spore antigens. The antisera obtained in that study have been used to determine the immunological relationship between Cl. sporogenes and the proteolytic strains of Cl. botulinum by the indirect fluorescent antibody test (FAT). 
MATERIALS AND METHODS
These were similar to those used in previous reports (PrincewiU, 1978 (PrincewiU, , 1979a , with the addition of the following:
Cl. botulinum strains. Of the 31 strains ( These strains have been given serial numbers which have been used in this investigation.
RESULTS

Screening with Cl. sporogenes spore antisera
To determine the extent of sharing of spore antigens by strains of Cl. sporogenes and Cl. botulinum, spores were prepared from the 31 strains of Cl. botulinum and screened with the spore antisera prepared against strains of Cl. sporogenes (Princewill, 1979a) by FAT.
The results summarized in Table 2 show that there was no regular pattern of reaction between the spore antisera of Cl. sporogenes and the spores of strains of Cl. botulinum. Even antisera of the same type of Cl. sporogenes did not always react with the same strains of Cl. botulinum. Moreover, the cross-reactions among the strains of Cl. botulinum did not agree with the toxigenic type; there was no reaction with the 3 strains of type F tested and some of the strains of types A andB.
Cross-fluorescence tests In the light of the results of the preliminary screening tests, one strain each of Cl. botulinum type A (strain 188) and type B (strain 172) was selected for the production of spore antisera. A strain of type F could not be included, because none of the strains sporulated sufficiently to provide spores for immunization. The two spore antisera obtained were then used along with the Cl. sporogenes antisera in cross-fluorescence tests.
The results (Table 3) show that both antisera to Cl. botulinum types A and B fluoresced to full titre with all the strains of homologous and heterologous types. This confirms that the spore antigens of Cl. botulinum are not related to the toxins produced by this organism. The cross-fluorescence of strains of Cl. sporogenes was of a low titre and the pattern of reaction did not follow any regular order, some strains of a type reacting whereas others did not.
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-. Immunofluorescence cross-absorption tests. To observe the degree of sharing of spore antigens, cross-absorption tests were conducted on some of the antisera with a few selected strains of both Cl. sporogenes and Cl. botulinum.
The results show that the cross-reacting antibodies could be removed by absorption. Thus, in the sporogenes-antisporogenes system (Tables 4-6) homologous absorption removed all the spore antibodies in the serum whereas heterologous absorption removed a substantial proportion of spore fluorescent T. J. T. PBINCEWIIX antibodies. In the botulinum-antibotulinum system (Tables 7, 8 ), homologous and heterologous absorptions removed all the spore antibodies in the serum thus confirming that the proteolytic strains of Cl. botulinum types A and B have identical spore antigens. In the botulinum-antisporogenes (and vice versa) crossabsorption systems, spores of Cl. botulinum types A and B removed the low titre cross-reacting antibodies in Cl. sporogenes antisera, thus rendering the antisera specific for Cl. sporogenes types; the reverse held good when Cl. botulinum antisera were absorbed with spores of Cl. sporogenes.
DISCUSSION
Cl. botulinum is divided into six types (A-F) on the basis of antigenically distinct toxins that they produce but their biochemical activity separates them into proteolytic and non-proteolytic groups. Because of serological differences in their vegetative antigens, the two biochemical groups have been considered as two separate species. Thus, the proteolytic group, consisting of Cl. botulinum types A, B and F have been considered as representing or belonging to Cl. parabotulinum whilst the non-proteolytic types B, C, D, E and F are members of Cl. botulinum (Bengtson, 1924) . In this investigation we have not followed this nomenclature rigidly, but have used both names when appropriate. However, since our other organism of study is Cl. sporogenes, which is a strongly proteolytic species, the comparative studies were made between Cl. sporogenes and Cl. parabotulinum although we have continued to use the term Cl. botulinum for these.
On morphological, cultural and biochemical grounds, non-toxigenic Cl. parabotulinum is indistinguishable from Cl. sporogenes. Somatic and flagellar crossagglutination between the two species has been reported (Mandia, 1951 (Mandia, , 1955 Solomon et al. 1971; Lynt, Solomon & Kautter, 1972) . Meisel & Rymkiewicz (1959) , however, did not find any cross-reactions by spore agglutination among strains of Cl. sporogenes and Cl. botulinum types A and B (proteolytic). This is not surprising as they used only a small number of strains (three) of each species. In this study, FAT was used to examine 31 strains of Cl. parabotulinum (types A, 18; B, 10; and F, 3) . Table 2 shows that the spores of the strains fluoresced in Cl. sporogenes spore antisera but there was no regular pattern of reactions; antisera of the same type of Cl. sporogenes did not consistently react with the same strains of Cl. botulinum; the cross-reacting strains of Cl. botulinum did not correspond to the toxigenic types; the three strains of Cl. botulinum type F and some strains of types A and B showed no reaction with any of the Cl. sporogenes antisera. These latter results are reminiscent of the experience of Meisel & Rymkiewicz (1959) .
A two-way cross-fluorescence test (see Table 3 ) shows that the two antisera to Cl. botulinum types A (Strain 188) and B (strain 172) fluoresced to full titre with all the strains of the homologous and heterologous types. This again shows that there is no relation between the spore antigens of Cl. botulinum and the potential toxin production by types of this organism. This result does not agree with the findings of Meisel & Rymkiewicz (1959) , who did not show any cross-agglutination between spores of Cl. botulinum types A and B. This is surprising since sharing of vegetative antigens among the proteolytic Cl. botulinum (i.e. Cl. parabotulinum) has been reported by Mandia (1951) and others. It is possible that Meisel & Rymkiewicz (1959) were dealing with examples of incomplete antibodies which failed to bring about agglutination of the spore suspensions; FAT might have given a positive reaction. The two-way cross-fluorescence tests show a great deal of cross-reaction among strains of Cl. sporogenes and Cl. parabotulinum types A and B, even though the cross-reacting titres are lower than those given by specific homologous antisera.
Cross-absorption of the antisera suggests the presence of more than one antigenic component (Tables 4-8) . The different types of Cl. sporogenes share a component with Cl. parabotulinum types A and B; this component removes the cross-reacting antibody thereby rendering the botulinum antisera specific for this species. It is also responsible for the slight lowering of the titre in the sporogenes antisera when absorbed with botulinum spores. Another component is shared exclusively by types of Cl. botulinum including the three type-F strains (not shown in the Tables) and this is responsible for species specificity. We name this L and the group-specific component M (following the sequence of the spore antigenic components described by Princewill, 1979a, b) , which is possessed by some strains of Cl. sporogenes. Some strains of Cl. histolyticum type II (Princewill, 19796) also possessed component M which was absent from the strains of Cl. bifermentans and Cl. butyricum studied by Princewill (1979&) . Table 9 shows the distribution of spore antigenic components among strains of the species of Clostridium studied in the series.
